Brachytherapy
Recent research presented at a conference in Boston has shed light on the effectiveness of different external beam radiation therapy (EBRT) dosing regimens prior to brachytherapy in patients with clinically localized prostate cancer. The study, led by researchers from the Dana-Farber Cancer Institute, aimed to evaluate whether different dosing regimens
Cancer research
In a promising development for patients with estrogen receptor-positive (ER+)/HER2-negative (HER2-) metastatic breast cancer, elacestrant has been shown to significantly prolong progression-free survival (PFS) and improve clinical outcomes in patients who have not been treated with CDK4/6 inhibitors (CDK4/6i). The phase 3 EMERALD trial found that elacestrant
Cancer research
Researchers from Foch Hospital in Suresnes, France, have published a study on the use of FDG-PET/CT in assessing the response to Pembrolizumab in metastatic bladder cancer patients. The study aimed to evaluate the prognostic value of FDG-PET/CT in early assessment of response to Pembrolizumab. The researchers found that
Cancer research
Researchers at the University of Alabama Birmingham have made a breakthrough in cancer treatment by implementing remote symptom monitoring (RSM) with electronic patient-reported outcomes. The study found that patients who received RSM had a 19% lower hospitalization rate at 3 months and a 13% lower hospitalization rate at 6 months
Cancer research
Research from Boston, Massachusetts, has identified SRY-related HMG box gene 17 (SOX17) as a potential therapeutic target for immune evasion of colorectal cancer. Despite advances in cancer immunotherapies, survival outcomes in colorectal cancer remain largely unsatisfactory. Colorectal stem cells, especially LGR5+ CSCs, are the significant drivers in CRC initiation, progression,
Cancer research
Researchers at Zunyi Medical University have made significant progress in the development of a novel combination therapy for treating non-small cell lung cancer (NSCLC). The study, published in Technology in Cancer Research & Treatment, investigated the efficacy and safety of combining anti-angiogenic agents, such as recombinant human vascular endothelial inhibitor
Cancer research
Research on prostate cancer has been gaining traction, with a new study shedding light on the potential uses of immunotherapy in treating this disease. Immunotherapy, which harnesses the power of the immune system to fight cancer, has been shown to be effective in treating melanoma and lung cancer, but its
Cancer research
Researchers from King Faisal University in Saudi Arabia have made a significant discovery in the field of cancer gene therapy, specifically in the treatment of hepatocellular carcinoma (HCC). According to a recent study published in Pharmaceutics, the team has found that combining nanotechnology with natural products has emerged as a
Cancer research
A recent study from Zhejiang University has shed new light on the potential of gut bacteria in cancer treatment, revealing their remarkable anticancer properties and diverse mechanisms of action against tumor cells. The research, published in Microbiology Research in 2025, discusses the utilization of gut bacteria as therapeutic agents against
Cancer research
A team of researchers at Cincinnati Children's Hospital Medical Center has made significant progress in cancer gene therapy, as revealed in a new study published in Molecular Therapy: Methods & Clinical Development. The research, focused on sickle cell anemia, demonstrates the efficacy of a modified gamma-globin lentivirus gene
Cancer research
The Breast International Group (BIG) and Paige, a leader in next-generation AI technology, have formed a new partnership to conduct collaborative research aimed at enhancing breast cancer diagnosis, treatment, and patient outcomes. By combining BIG's clinical expertise and comprehensive patient datasets with Paige's advanced AI capabilities,
Cancer research
Research from the Laboratory for Molecular Biology, funded by Cancer Research UK and UK Research & Innovation (UKRI), has found that patients with active cancer have a higher risk of mortality and hospitalization from COVID-19 compared to those without cancer. The study, which analyzed 30 studies involving over 299,000
